Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide

European Journal of Pharmacology

Volumn 620, Issue 1-3, 2009, Pages 138-144

  Shin, Soona ^a   Wakabayashi, Junko ^b   Yates, Melinda S ^a   Wakabayashi, Nobunao ^b   Dolan, Patrick M ^b   Aja, Susan ^a   Liby, Karen T ^c   Sporn, Michael B ^c   Yamamoto, Masayuki ^d   Kensler, Thomas W ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Johns Hopkins University   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diet induced obesity; Fatty acid synthase; Nrf2; Triterpenoid

Indexed keywords

2 CYANO 3,12 DIOXOOLEANA 1,9 DIEN 28 OIC ACID; ACETYL COENZYME A CARBOXYLASE; FAT; FATTY ACID; GLUTATHIONE TRANSFERASE A1; LIPID; OXYGEN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR NRF2;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENERGY EXPENDITURE; FATTY ACID SYNTHESIS; FATTY LIVER; FEEDING; FEMALE; FOOD INTAKE; GENE DISRUPTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; LIPID DIET; LIPID STORAGE; MOUSE; NONHUMAN; OBESITY; ORGAN WEIGHT; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE;

ADIPOCYTES; ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; DIETARY FATS; ENERGY METABOLISM; FATTY ACIDS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMIDAZOLES; LIVER; MICE; NF-E2-RELATED FACTOR 2; OBESITY; OLEANOLIC ACID; OXIDATION-REDUCTION;

EID: 70349140473     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.08.022     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention (http://www.cdc.gov/nccdphp/dnpa/obesity/index.htm).
2. Cerulli J., Lomaestro B.M., and Malone M. Update on the pharmacotherapy of obesity. Ann. Pharmacother. 41 (2007) 1505-1517
3. Dinkova-Kostova A.T., Liby K.T., Stephenson K.K., Holtzclaw W.D., Gao X., Suh N., Williams C., Risingsong R., Honda T., Gribble G.W., Sporn M.B., and Talalay P. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4584-4589
4. Ginter E., and Simko V. Adult obesity at the beginning of the 21st century: epidemiology, pathophysiology and health risk. Bratisl. Lek. Listy 109 (2008) 224-230
5. Hughes D.T., Martel P.M., Kinlaw W.B., and Eisenberg B.L. The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells. Cancer Invest. 26 (2008) 118-127
6. Iida K., Itoh K., Kumagai Y., Oyasu R., Hattori K., Kawai K., Shimazui T., Akaza H., and Yamamoto M. Nrf2 is essential for the chemopreventive effi{ligature}cacy of oltipraz against urinary bladder carcinogenesis. Cancer Res. 64 (2004) 6424-6431
7. Kensler T.W., Wakabayashi N., and Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 89-116
8. Lusk G. The Elements of the Science of Nutrition. fourth ed. (1928), WB Saunders, Philadelphia, PA
9. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
10. Pope T.S., and Rooney S.A. Effects of glucocorticoid and thyroid hormones on regulatory enzymes of fatty acid synthesis and glycogen metabolism in developing fetal rat lung. Biochim. Biophys. Acta 918 (1987) 141-148
11. Qureshi K., and Abrams G.A. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver. World J. Gastroenterol. 13 (2007) 3540-3553
12. Rosen E.D. The transcriptional basis of adipocyte development. Prostaglandins Leukot. Essent. Fatty Acids 73 (2005) 31-34
13. Rosen E.D., and MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev., Mol. Cell. Biol. 7 (2006) 885-896
14. Shin S., Wakabayashi N., Misra V., Biswal S., Lee G.H., Agoston E.S., Yamamoto M., and Kensler T.W. NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis. Mol. Cell. Biol. 27 (2007) 7188-7197
15. Sussan T.E., Rangasamy T., Blake D.J., Malhotra D., El-Haddad H., Bedja D., Yates M.S., Kombairaju P., Yamamoto M., Liby K.T., Sporn M.B., Gabrielson K.L., Champion H.C., Tuder R.M., Kensler T.W., and Biswal S. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 250-255
16. Tanaka Y., Aleksunes L.M., Yeager R.L., Gyamfi M.A., Esterly N., Guo G.L., and Klaassen C.D. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J. Pharmacol. Exp. Ther. 325 (2008) 655-664
17. Toye A.A., Dumas M.E., Blancher C., Rothwell A.R., Fearnside J.F., Wilder S.P., Bihoreau M.T., Cloarec O., Azzouzi I., Young S., Barton R.H., Holmes E., McCarthy M.I., Tatoud R., Nicholson J.K., Scott J., and Gauguier D. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia 50 (2007) 1867-1879
18. Weigle D.S. Pharmacological therapy of obesity: past, present, and future. J. Clin. Endocrinol. Metab. 88 (2003) 2462-2469
19. Winzell M.S., and Ahrén B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53 Suppl 3 (2004) S215-S219
20. Wolfgang M.J., and Lane M.D. The role of hypothalamic malonyl-CoA in energy homeostasis. J. Biol. Chem. 281 (2006) 37265-37269
21. Yang J., Goldstein J.L., Hammer R.E., Moon Y.A., Brown M.S., and Horton J.D. Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13607-13612
22. Yates M.S., Kwak M.K., Egner P.A., Groopman J.D., Bodreddigari S., Sutter T.R., Baumgartner K.J., Roebuck B.D., Liby K.T., Yore M.M., Honda T., Gribble G.W., Sporn M.B., and Kensler T.W. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-, 12-dioxooleana-1, 9(11)-dien-28-oyl]imidazole. Cancer Res. 66 (2006) 2488-2494
23. Yates M.S., Tauchi M., Katsuoka F., Flanders K.C., Liby K.T., Honda T., Gribble G.W., Johnson D.A., Johnson J.A., Burton N.C., Guilarte T.R., Yamamoto M., Sporn M.B., and Kensler T.W. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol. Cancer Ther. 6 (2007) 154-162
24. Yates M.S., Tran Q.T., Dolan P.M., Osburn W.O., Shin S., McCulloch C.C., Silkworth J.B., Taguchi K., Yamamoto M., Williams C.R., Liby K.T., Sporn M.B., Sutter T.R., and Kensler T.W. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 30 (2009) 1024-1031